+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Cancer Screening Market - Global Forecast 2026-2032- Product Image
Canine Cancer Screening Market - Global Forecast 2026-2032- Product Image
Sale

Canine Cancer Screening Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125291
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Cancer Screening Market is projected to reach USD 325.65 Million in 2026. It is expected to continue growing at a CAGR of 4.60%, reaching USD 419.36 Million by 2032.

Canine Cancer Screening: Executive Overview

Canine cancer screening encompasses veterinary approaches used to identify malignancy or cancer-associated risk before definitive clinical diagnosis. The field combines physical examinations, laboratory testing, imaging, cytology, biopsy, and emerging molecular methods. Its development is shaped by the rising importance of preventive pet care, improved diagnostic capabilities, owner awareness, and the need to distinguish screening from confirmatory diagnosis and treatment planning.

How Preventive Veterinary Care Is Reshaping Screening

The landscape is shifting from symptom-led evaluation toward more structured risk assessment, particularly for older dogs, breeds with inherited predispositions, and animals with relevant medical histories. Progress in laboratory workflows, digital imaging, pathology, and sample logistics is supporting earlier clinical decision-making. Adoption remains influenced by test interpretation, false-positive and false-negative risks, veterinary capacity, affordability, owner consent, and the availability of follow-up diagnostics.

Artificial Intelligence Strengthens Detection and Workflow Support

Artificial intelligence is increasingly relevant to canine cancer screening through image interpretation, pathology assistance, biomarker pattern recognition, clinical decision support, and laboratory quality control. Its greatest near-term value is likely to come from prioritizing cases, identifying subtle abnormalities, and improving consistency rather than replacing veterinary judgment. Reliable deployment requires representative canine datasets, external validation, transparent performance measures, interoperability with practice systems, privacy safeguards, and clear responsibility for clinical decisions.

Regional Differences Reflect Veterinary Capacity and Care Models

North America generally benefits from established specialty veterinary services, advanced diagnostic infrastructure, and comparatively strong awareness of preventive care. Europe combines sophisticated veterinary medicine with varied national reimbursement, regulatory, and data-governance environments. Asia-Pacific presents substantial diversity, with advanced urban systems alongside uneven access in rural areas. Latin America is shaped by differences in household spending, laboratory availability, and specialist coverage. The Middle East shows concentration of advanced services in major urban centers, while Africa faces wider constraints in diagnostic access, referral networks, and veterinary workforce distribution.

Cross-Group Priorities Differ Across ASEAN, BRICS, the European Union, G7, GCC, and NATO

ASEAN markets reflect diverse levels of veterinary infrastructure and cross-border regulatory maturity, making adaptable workflows and training important. BRICS economies span large differences in laboratory capacity, urbanization, and access to specialty care. The European Union places strong emphasis on harmonized standards, animal welfare, and data governance. G7 countries generally have mature clinical ecosystems but continue to address cost, capacity, and evidence requirements. GCC countries tend to emphasize advanced urban veterinary services and imported technologies, while NATO members represent varied national systems linked more by cooperation and shared interest in resilience, standards, and innovation than by a single veterinary-care model.

Country Context Shapes Adoption, Access, and Clinical Integration

Australia and Canada combine broad geographic coverage challenges with developed veterinary sectors. Brazil, Mexico, India, Russia, and South Africa face substantial regional variation in access and laboratory capability. China, Japan, and South Korea have strong urban veterinary ecosystems alongside distinct regulatory and practice environments. France, Germany, Italy, Spain, and the United Kingdom have established companion-animal care systems, with differences in reimbursement, referral pathways, and data practices. In the United States, advanced specialty care and diagnostic innovation coexist with variation in affordability and access across communities. Across all countries, screening value depends on confirmatory testing, veterinary interpretation, and timely treatment options.

Prioritize Evidence, Workflow Integration, and Equitable Access

Industry leaders should define screening use cases precisely, separating population screening from risk-based testing and diagnostic evaluation. They should validate assays and algorithms against clinically meaningful outcomes, publish transparent performance data, and establish protocols for abnormal results. Integration with veterinary practice software, pathology services, imaging systems, and referral networks can reduce friction. Training should help clinicians communicate uncertainty and shared decisions with owners. Leaders should also develop tiered service models, strengthen sample handling and quality assurance, monitor performance across breeds and regions, and engage regulators and professional bodies early.

Methodology: Evidence-Led Synthesis of Clinical and Market-Context Signals

This executive summary uses the defined canine cancer screening market scope and organizes findings across technology, clinical workflow, regional conditions, country context, and stakeholder groups. The analysis prioritizes verifiable themes reported through veterinary clinical literature, diagnostic practice developments, regulatory considerations, and documented healthcare-system characteristics. It avoids unsupported numerical claims and treats artificial intelligence as an enabling capability requiring clinical validation. Regional and group comparisons are qualitative because access, standards, reimbursement, and care pathways vary within each geography.

Conclusion: Screening Progress Depends on Trusted Clinical Utility

Canine cancer screening is advancing as preventive veterinary care, diagnostics, and digital tools become more connected. Sustainable progress will depend less on novelty alone than on clinically validated performance, responsible interpretation, accessible follow-up care, and integration into everyday veterinary workflows. Organizations that combine evidence, usability, transparent communication, and regional adaptability will be better positioned to improve earlier detection while protecting animal welfare and owner trust.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Canine Cancer Screening Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Imaging Instruments
7.2.2. Molecular Instruments
7.2.3. Sequencing Platforms
7.3. Reagents & Kits
7.3.1. Eliza Kits
7.3.2. NGS Kits
7.3.3. PCR Reagents
7.4. Services
7.4.1. Contract Research
7.4.2. Laboratory Services
8. Canine Cancer Screening Market, by Technology
8.1. Introduction
8.2. Biomarker Assays
8.2.1. Elisa
8.2.2. Immunohistochemistry
8.3. Genetic Testing
8.3.1. PCR Based
8.3.2. Sequencing Based
8.4. Imaging
8.4.1. CT
8.4.2. MRI
8.4.3. Ultrasound
8.4.4. X-Ray
8.5. Molecular Diagnostics
8.5.1. NGS
8.5.2. PCR
8.5.3. QPCR
9. Canine Cancer Screening Market, by Cancer Type
9.1. Introduction
9.2. Hemangiosarcoma
9.3. Lymphoma
9.4. Mammary Tumors
9.5. Skin Cancer
10. Canine Cancer Screening Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Fine Needle Aspirate
10.4. Saliva
10.5. Tissue Biopsy
10.6. Urine
11. Canine Cancer Screening Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.2.1. Clinical Laboratories
11.2.2. Reference Laboratories
11.3. Research Institutes
11.3.1. Academic Institutions
11.3.2. Private Research
11.4. Veterinary Clinics
11.4.1. Small Animal Clinics
11.4.2. Specialty Clinics
11.5. Veterinary Hospitals
11.5.1. Corporate Hospitals
11.5.2. Independent Hospitals
12. Canine Cancer Screening Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Canine Cancer Screening Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Canine Cancer Screening Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Animal Cancer Care and Research, Inc.
16.2. Anivive Lifesciences, Inc.
16.3. Biomérieux SA
16.4. BluePearl Veterinary Partners, LLC
16.5. Cancan Diagnostics AB
16.6. Cutting Edge Laser Technologies, LLC
16.7. Embark Veterinary, Inc.
16.8. Heska Corporation
16.9. IDEXX Laboratories, Inc.
16.10. LiteCure LLC
16.11. Mars Petcare, Inc.
16.12. Oncotect, Inc.
16.13. Pathway Vet Alliance, Inc.
16.14. PetDx, Inc.
16.15. Petnostics Ltd.
16.16. Siemens Healthineers AG
16.17. Torigen Specialty Pathology, Inc.
16.18. VetDC, Inc.
16.19. VetGen, LLC
16.20. VolitionRx Limited
16.21. Wuxi AppTec
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Canine Cancer Screening Market, Years Considered for the Study
FIGURE 2. Global Canine Cancer Screening Market, Research Design
FIGURE 3. Global Canine Cancer Screening Market, Research Framework
FIGURE 4. Global Canine Cancer Screening Market, Data Triangulation
FIGURE 5. Global Canine Cancer Screening Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Canine Cancer Screening Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Canine Cancer Screening Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Canine Cancer Screening Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Canine Cancer Screening Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Canine Cancer Screening Market Size, by Cancer Type, 2025 vs 2032 (%)
FIGURE 11. Global Canine Cancer Screening Market Size, by Cancer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Canine Cancer Screening Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Canine Cancer Screening Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Canine Cancer Screening Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Canine Cancer Screening Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Canine Cancer Screening Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Canine Cancer Screening Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Canine Cancer Screening Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Canine Cancer Screening Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Canine Cancer Screening Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Canine Cancer Screening Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Canine Cancer Screening Market Segmentation & Coverage
TABLE 2. Global Canine Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 3. Global Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Imaging Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Imaging Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Imaging Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Molecular Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Molecular Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Molecular Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Sequencing Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Sequencing Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Sequencing Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Eliza Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Eliza Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Eliza Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global NGS Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global NGS Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global NGS Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Contract Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Contract Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Contract Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Laboratory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Laboratory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Laboratory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 38. Global Biomarker Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Biomarker Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Biomarker Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Elisa Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Elisa Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Elisa Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Immunohistochemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Immunohistochemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Immunohistochemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global PCR Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global PCR Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global PCR Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Sequencing Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Sequencing Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Sequencing Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global X-Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global X-Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global X-Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global NGS Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global NGS Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global NGS Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global QPCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global QPCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global QPCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 84. Global Hemangiosarcoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Hemangiosarcoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Hemangiosarcoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Lymphoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Lymphoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Lymphoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Mammary Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Mammary Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Mammary Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Skin Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Skin Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Skin Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 97. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Fine Needle Aspirate Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Fine Needle Aspirate Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Fine Needle Aspirate Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Tissue Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Tissue Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Tissue Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Private Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Private Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Private Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Small Animal Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Small Animal Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Small Animal Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Corporate Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Corporate Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Corporate Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Independent Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Independent Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Independent Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 167. North America Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. North America Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. North America Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 170. North America Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 171. North America Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 172. North America Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. North America Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 174. North America Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 175. North America Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 176. North America Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 177. North America Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 178. North America Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 179. North America Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. North America Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 181. North America Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 182. North America Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 183. North America Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 184. Latin America Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Latin America Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Latin America Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 187. Latin America Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 188. Latin America Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 189. Latin America Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. Latin America Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 191. Latin America Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 192. Latin America Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 193. Latin America Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 194. Latin America Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 195. Latin America Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 196. Latin America Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Latin America Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 198. Latin America Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 199. Latin America Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 200. Latin America Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 201. Europe Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Europe Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Europe Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 204. Europe Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 205. Europe Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 206. Europe Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 207. Europe Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 208. Europe Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 209. Europe Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 210. Europe Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 211. Europe Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 212. Europe Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. Europe Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Europe Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 215. Europe Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 216. Europe Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 217. Europe Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 218. Middle East Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Middle East Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. Middle East Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 221. Middle East Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 222. Middle East Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 223. Middle East Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Middle East Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 225. Middle East Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 226. Middle East Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 227. Middle East Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 228. Middle East Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 229. Middle East Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 230. Middle East Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Middle East Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 232. Middle East Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 233. Middle East Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 234. Middle East Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 235. Africa Canine Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 236. Africa Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Africa Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 238. Africa Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 239. Africa Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 240. Africa Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. Africa Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 242. Africa Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 243. Africa Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 244. Africa Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 245. Africa Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 246. Africa Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 247. Africa Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Africa Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 249. Africa Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 250. Africa Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 251. Africa Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 252. Global Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. ASEAN Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. ASEAN Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. ASEAN Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 256. ASEAN Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 257. ASEAN Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 258. ASEAN Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 259. ASEAN Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 260. ASEAN Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 261. ASEAN Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 262. ASEAN Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 263. ASEAN Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 264. ASEAN Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. ASEAN Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. ASEAN Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 267. ASEAN Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 268. ASEAN Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 269. ASEAN Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 270. GCC Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. GCC Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. GCC Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 273. GCC Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 274. GCC Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 275. GCC Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 276. GCC Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 277. GCC Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 278. GCC Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 279. GCC Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 280. GCC Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 281. GCC Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 282. GCC Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. GCC Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 284. GCC Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 285. GCC Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 286. GCC Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 287. European Union Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. European Union Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. European Union Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 290. European Union Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 291. European Union Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 292. European Union Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. European Union Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 294. European Union Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 295. European Union Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 296. European Union Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 297. European Union Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 298. European Union Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 299. European Union Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. European Union Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 301. European Union Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 302. European Union Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 303. European Union Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 304. BRICS Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 305. BRICS Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. BRICS Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 307. BRICS Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 308. BRICS Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 309. BRICS Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 310. BRICS Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 311. BRICS Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 312. BRICS Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 313. BRICS Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 314. BRICS Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 315. BRICS Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 316. BRICS Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. BRICS Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 318. BRICS Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 319. BRICS Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 320. BRICS Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 321. G7 Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 322. G7 Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 323. G7 Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 324. G7 Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 325. G7 Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 326. G7 Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 327. G7 Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 328. G7 Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 329. G7 Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 330. G7 Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 331. G7 Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 332. G7 Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 333. G7 Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. G7 Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 335. G7 Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 336. G7 Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 337. G7 Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 338. NATO Canine Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 339. NATO Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 340. NATO Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 341. NATO Canine Cancer Screening Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 342. NATO Canine Cancer Screening Market Size, by Services, 2017-2032 (USD Million)
TABLE 343. NATO Canine Cancer Screening Market Size, by Technology, 2017-2032 (USD Million)
TABLE 344. NATO Canine Cancer Screening Market Size, by Biomarker Assays, 2017-2032 (USD Million)
TABLE 345. NATO Canine Cancer Screening Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 346. NATO Canine Cancer Screening Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 347. NATO Canine Cancer Screening Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 348. NATO Canine Cancer Screening Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 349. NATO Canine Cancer Screening Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 350. NATO Canine Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 351. NATO Canine Cancer Screening Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 352. NATO Canine Cancer Screening Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 353. NATO Canine Cancer Screening Market Size, by Veterinary Clinics, 2017-2032 (USD Million)
TABLE 354. NATO Canine Cancer Screening Market Size, by Veterinary Hospitals, 2017-2032 (USD Million)
TABLE 355. Global Canine Cancer Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 356. United States Canine Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 357. United States Canine Cancer Screening Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 358. United States Canine Cancer Screening Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 359. United States Canine Cancer Screening Market Size, by R

Companies Mentioned

  • Animal Cancer Care and Research, Inc.
  • Anivive Lifesciences, Inc.
  • Biomérieux SA
  • BluePearl Veterinary Partners, LLC
  • Cancan Diagnostics AB
  • Cutting Edge Laser Technologies, LLC
  • Embark Veterinary, Inc.
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • LiteCure LLC
  • Mars Petcare, Inc.
  • Oncotect, Inc.
  • Pathway Vet Alliance, Inc.
  • PetDx, Inc.
  • Petnostics Ltd.
  • Siemens Healthineers AG
  • Torigen Specialty Pathology, Inc.
  • VetDC, Inc.
  • VetGen, LLC
  • VolitionRx Limited
  • Wuxi AppTec

Related Topics

Related Reports

Oral Cancer Screening Device Market - Global Forecast 2026-2032 - Product Image

Oral Cancer Screening Device Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Gynecological Cancer Screening Device Market - Global Forecast 2026-2032 - Product Image

Gynecological Cancer Screening Device Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Lung Cancer Screening Software - Global Strategic Business Report - Product Image

Lung Cancer Screening Software - Global Strategic Business Report

  • Report
  • 98 Pages
  • Global
From
Colorectal Cancer Screening Tests - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Colorectal Cancer Screening Tests - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 188 Pages
  • Global
From
Cancer Screening Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035) - Product Image

Cancer Screening Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.